Cash and Short Term Investments (Quarterly) Chart

View Cash and Short Term Investments (Quarterly) for HROW.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash and Short Term Investments (Quarterly) Chart
Start Trial

Historical Cash and Short Term Investments (Quarterly) Data

View and export this data back to 2007. Start Trial.
Date Value
June 30, 2026 83.89M
March 31, 2026 94.64M
December 31, 2025 72.93M
September 30, 2025 74.29M
June 30, 2025 52.96M
March 31, 2025 66.73M
December 31, 2024 47.25M
September 30, 2024 72.60M
June 30, 2024 70.97M
March 31, 2024 75.97M
December 31, 2023 82.77M
September 30, 2023 73.88M
June 30, 2023 29.67M
March 31, 2023 26.88M
December 31, 2022 101.86M
September 30, 2022 49.12M
June 30, 2022 51.63M
March 31, 2022 50.59M
December 31, 2021 50.67M
September 30, 2021 67.84M
June 30, 2021 85.06M
March 31, 2021 32.12M
December 31, 2020 32.76M
September 30, 2020 33.38M
June 30, 2020 23.18M
Date Value
March 31, 2020 18.47M
December 31, 2019 30.15M
September 30, 2019 25.75M
June 30, 2019 31.84M
March 31, 2019 32.26M
December 31, 2018 28.26M
September 30, 2018 6.315M
June 30, 2018 4.17M
March 31, 2018 2.892M
December 31, 2017 4.219M
September 30, 2017 4.067M
June 30, 2017 4.365M
March 31, 2017 7.596M
December 31, 2016 9.053M
September 30, 2016 2.812M
June 30, 2016 5.591M
March 31, 2016 11.97M
December 31, 2015 2.835M
September 30, 2015 6.706M
June 30, 2015 10.20M
March 31, 2015 3.048M
December 31, 2014 8.362M
September 30, 2014 10.51M
June 30, 2014 12.25M
March 31, 2014 14.25M

Cash and Short Term Investments Definition

Represents the sum of cash and short term investments.

Read full definition.

Cash and Short Term Investments (Quarterly) Range, Past 5 Years

View Cash and Short Term Investments (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash and Short Term Investments (Quarterly) Benchmarks

View Cash and Short Term Investments (Quarterly) Benchmarks
Start Trial
Viatris, Inc. 1.410B
Zevra Therapeutics, Inc. 221.57M
Indivior Pharmaceuticals, Inc. 222.00M
Liquidia Corp. 284.18M
60 Degrees Pharmaceuticals, Inc. 1.023M